Bullish signal on weekly chart

Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
| Open | 4,297.00 |
| High | 4,310.50 |
| Low | 4,262.00 |
| Prev Close | 4,272.20 |
| Volume | 18,396 |
| VWAP(₹) | 4,288.35 |
| PE Ratio(x) | 28.03 |
| EPS - TTM(₹) | 153.35 |
| MCap(₹ Cr.) | 19,317.91 |
| MCap Rank | 5 |
| PB Ratio(x) | 6.47 |
| Div Yield(%) | 3.49 |
| Face Value(₹) | 10.00 |
| 52W High(₹) | 6,511.00 |
| 52W Low(₹) | 4,232.00 |
| MCap/Sales | 3.68 |
| Beta(1 Month) | 1.13 |
| BV/Share(₹) | 659.89 |
Intraday fact check
In the last 16 years, only 1.3 % trading sessions saw intraday gains higher than 5 % .Zero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 7.72% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)Bayer Cropsc. Share Price Update
Bayer Cropscience Ltd. share price moved up by 0.62% from its previous close of Rs 4,272.20. Bayer Cropscience Ltd. stock last traded price is 4,298.40
| Share Price | Value |
|---|---|
| Today/Current/Last | 4,298.40 |
| Previous Day | 4,272.20 |
Found Insights useful?
| 1 Day | 0.62% |
| 1 Month | -6.76% |
| 3 Months | -6.64% |
| 1 Year | -20.83% |
| 3 Years | 0.96% |
| 5 Years | -19.68% |
8 Analysts
| Ratings | Current | 1W Ago | 1M Ago | 3M Ago |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 |
| Hold | 4 | 4 | 4 | 4 |
| Sell | - | - | - | - |
| Strong Sell | - | - | - | - |
| # Analysts | 8 | 8 | 8 | 8 |
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|
| Total Income | 1,122.10 | 1,567.20 | 1,933.30 | 1,083.50 | 1,089.60 |
| Total Income Growth (%) | -28.40 | -18.94 | 78.43 | -0.56 | -38.14 |
| Total Expenses | 1,003.90 | 1,362.50 | 1,593.40 | 909.90 | 1,052.30 |
| Total Expenses Growth (%) | -26.32 | -14.49 | 75.12 | -13.53 | -32.88 |
| EBIT | 118.20 | 204.70 | 339.90 | 173.60 | 37.30 |
| EBIT Growth (%) | -42.26 | -39.78 | 95.79 | 365.42 | -80.72 |
| Profit after Tax (PAT) | 95.70 | 152.70 | 278.70 | 143.30 | 34.20 |
| PAT Growth (%) | -37.33 | -45.21 | 94.49 | 319.01 | -74.91 |
| EBIT Margin (%) | 10.53 | 13.06 | 17.58 | 16.02 | 3.42 |
| Net Profit Margin (%) | 8.53 | 9.74 | 14.42 | 13.23 | 3.14 |
| Basic EPS (₹) | 21.29 | 33.98 | 62.01 | 31.88 | 7.61 |
All figures in Rs Cr, unless mentioned otherwise
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 7.72% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)| Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Assets | 5,245.90 | 4,597.10 | 4,678.60 | 4,352.90 | 4,239.30 |
| Total Assets Growth (%) | 14.11 | -1.74 | 7.48 | 2.68 | 10.52 |
| Total Liabilities | 2,395.50 | 1,747.70 | 1,966.50 | 1,828.60 | 1,689.00 |
| Total Liabilities Growth (%) | 37.07 | -11.13 | 7.54 | 8.27 | 33.71 |
| Total Equity | 2,850.40 | 2,849.40 | 2,712.10 | 2,524.30 | 2,550.30 |
| Total Equity Growth (%) | 0.04 | 5.06 | 7.44 | -1.02 | -0.86 |
| Current Ratio (x) | 2.01 | 2.44 | 2.19 | 2.15 | 2.26 |
| Total Debt to Equity (x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Contingent Liabilities | 695.80 | 562.90 | 372.70 | 366.60 | 292.30 |
All figures in Rs Cr, unless mentioned otherwise
Zero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)| Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash flow from Operating Activities | 262.00 | 951.60 | 609.30 | 215.50 | 686.70 |
| Net Cash used in Investing Activities | 85.60 | 0.40 | 83.30 | 64.20 | 6.70 |
| Net Cash flow from Financing Activities | -619.40 | -656.30 | -613.20 | -703.30 | -555.80 |
| Net Cash Flow | -271.80 | 295.70 | 79.40 | -423.60 | 137.60 |
| Closing Cash & Cash Equivalent | 885.00 | 1,156.50 | 860.30 | 780.90 | 1,204.50 |
| Closing Cash & Cash Equivalent Growth (%) | -23.48 | 34.43 | 10.17 | -35.17 | 12.90 |
| Total Debt/ CFO (x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
All figures in Rs Cr, unless mentioned otherwise
Cash from Operations vs PAT
Operating cash flow of Rs 37.73 cr is 0.68 times compared to the reported net profit of Rs 55.41 cr. (Source: Consolidated Financials)| Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Return on Equity (%) | 19.92 | 25.98 | 27.95 | 25.56 | 19.33 |
| Return on Capital Employed (%) | 23.96 | 32.03 | 31.31 | 29.74 | 30.05 |
| Return on Assets (%) | 10.82 | 16.10 | 16.20 | 14.82 | 11.63 |
| Interest Coverage Ratio (x) | 47.61 | 52.81 | 44.31 | 67.11 | 63.65 |
| Asset Turnover Ratio (x) | 1.11 | 1.10 | 1.14 | 1.10 | 100.51 |
| Price to Earnings (x) | 39.06 | 31.85 | 23.98 | 34.72 | 48.54 |
| Price to Book (x) | 7.76 | 8.26 | 6.70 | 8.86 | 9.34 |
| EV/EBITDA (x) | 26.23 | 21.62 | 17.52 | 24.93 | 25.83 |
| EBITDA Margin (%) | 14.78 | 20.28 | 19.22 | 18.28 | 20.54 |
Found Financials useful?
Stochastic Crossover
Bullish signal on weekly chart
Appeared on: 5 Jun 2026
Region: Oversold (Below 20)
Average price gain of 6.45% within 7 weeks of Bullish signal in last 10 years
Global Meltdown1st Jan 2008 to 10th Nov 2008
Covid Crisis1st Feb 2020 to 31st Mar 2020
| R1 | 4301.87 | Pivot 4281.93 | S1 | 4258.57 |
| R2 | 4325.23 | S2 | 4238.63 | |
| R3 | 4368.53 | S3 | 4195.33 |
| 5 Days | 14 Days | 28 Days |
| 87.38 | 103.72 | 111.85 |
Found Technicals useful?
Choose from Peers
Choose from Stocks
Found Peer Comparison useful?
MF Ownership as on 30 April 2026
494.14
Amount Invested (in Cr.)
1.626861%
% of AUM
0.00
% Change (MoM basis)
269.72
Amount Invested (in Cr.)
0.37%
% of AUM
0.71
% Change (MoM basis)
184.76
Amount Invested (in Cr.)
1.03%
% of AUM
28.49
% Change (MoM basis)
Board Meeting
Quarterly Results
Jan 27, 2026
Interim Dividend
900%
Nov 07, 2025
Board Meeting
Quarterly Results & Interim Dividend
Oct 17, 2025
| Announced on | Meeting on |
| Jan 27, 2026 | Feb 11, 2026 |
| Quarterly Results | |
| Oct 17, 2025 | Nov 07, 2025 |
| Quarterly Results & Interim Dividend | |
| Jul 21, 2025 | Aug 06, 2025 |
| Quarterly Results | |
| May 05, 2025 | May 26, 2025 |
| Audited Results & Final Dividend | |
| Jan 21, 2025 | Feb 11, 2025 |
| Quarterly Results | |
| Announced on | Ex-Date | Dividend% |
| Nov 07, 2025 | Nov 14, 2025 | 900% |
| May 26, 2025 | Aug 07, 2025 | 350% |
| Nov 14, 2024 | Nov 28, 2024 | 900% |
| May 23, 2024 | Aug 01, 2024 | 350% |
| Nov 03, 2023 | Nov 16, 2023 | 1050% |
| Announced on | Ex-Date |
| Jul 24, 1993 | - |
| Bonus Ratio: 1 share(s) for every 1 shares held | |
| Oct 05, 1987 | - |
| Bonus Ratio: 1 share(s) for every 1 shares held | |
| Aug 08, 1977 | - |
| Bonus Ratio: 1 share(s) for every 1 shares held | |
| Aug 08, 1972 | - |
| Bonus Ratio: 1 share(s) for every 5 shares held | |
| Announced on | Ex-Date |
| May 19, 2003 | Nov 24, 2003 |
| Split: Old FV100.0| New FV:10.0 | |
No Data Available
| Announced on | Meeting on |
| Jul 03, 2025 | Aug 21, 2025 |
| - | |
| Feb 24, 2025 | Apr 04, 2025 |
| - | |
| Jul 02, 2024 | Aug 14, 2024 |
| Book closure from Aug 2, 2024 to Aug 9, 2024 | |
| Feb 23, 2024 | Mar 27, 2024 |
| - | |
| Nov 30, 2023 | Jan 05, 2024 |
| - | |
Bayer Cropscience Ltd., incorporated in the year 1958, is a Mid Cap company (having a market cap of Rs 19,317.91 Crore) operating in Pesticides/Agro Chemicals sector.
Industry
Key Indices Listed On
Nifty 500, BSE 500, BSE MidCap, BSE 250 LargeMidCap Index, BSE Commodities
Address
Bayer House,Central Avenue,Hiranandani Estate,Mumbai, Maharashtra - 400607
Pankaj Ramanbhai Patel
Chairman & Ind.Dire (Non-Exe)Simon Thorsten Wiebusch
Vice Chairman & Mng.DirectorSimon Thorsten Wiebusch
Chief Executive OfficerVinit Rajesh Jindal
Executive Director & CFODATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.